FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weisgraber, K. H.
Right arrow Articles by Mahley, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weisgraber, K. H.
Right arrow Articles by Mahley, R. W.

The FASEB Journal, Vol 10, 1485-1494, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Human apolipoprotein E: the Alzheimer's disease connection

KH Weisgraber and RW Mahley
Gladstone Institute of Cardiovascular Disease, University of California at San Francisco, 94141-9100, USA.

Human apolipoprotein (apo) E, long known for its prominent role in cholesterol transport and plasma lipoprotein metabolism, has recently emerged as a major genetic risk factor for Alzheimer's disease, a neurodegenerative disorder. In a variety of populations worldwide, one of the three common alleles of apoE, apoE4, is overrepresented in Alzheimer's subjects compared with age- and sex-matched controls. The genetic and epidemiologic evidence suggests that apoE is a major susceptibility gene for Alzheimer's disease; it likely accounts for a major portion of the genetic heterogeneity in the disease. Although its role in the development of Alzheimer's disease is unknown, biochemical and cell biology studies are providing important insights into how apoE may be involved in neurodegenerative disorders. Based on an understanding of the structure and function of apoE in lipid transport and cellular metabolism, it is suggested that apoE is involved in a final common pathway of neuronal repair and remodeling: apoE3 (most common allele) supporting effective repair and remodeling after neuronal injury by noxious agents, and apoE4 being less effective in these processes.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
J. Neurosci., February 6, 2008; 28(6): 1452 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Shi, C. B. Zhao, T. L. Vollmer, T. M. Tyry, and S. M. Kuniyoshi
APOE {varepsilon}4 allele is associated with cognitive impairment in patients with multiple sclerosis
Neurology, January 15, 2008; 70(3): 185 - 190.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. F. Burk, K. E. Hill, G. E. Olson, E. J. Weeber, A. K. Motley, V. P. Winfrey, and L. M. Austin
Deletion of Apolipoprotein E Receptor-2 in Mice Lowers Brain Selenium and Causes Severe Neurological Dysfunction and Death When a Low-Selenium Diet Is Fed
J. Neurosci., June 6, 2007; 27(23): 6207 - 6211.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. M. Wang, R. W. Irwin, and R. D. Brinton
Activation of estrogen receptor {alpha} increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo
PNAS, November 7, 2006; 103(45): 16983 - 16988.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. D. Tetali, M. S. Budamagunta, J. C. Voss, and J. C. Rutledge
C-terminal interactions of apolipoprotein E4 respond to the postprandial state
J. Lipid Res., July 1, 2006; 47(7): 1358 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. S. Burgos, C. Ramirez, I. Sastre, and F. Valdivieso
Effect of apolipoprotein e on the cerebral load of latent herpes simplex virus type 1 DNA.
J. Virol., June 1, 2006; 80(11): 5383 - 5387.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
PNAS, April 11, 2006; 103(15): 5644 - 5651.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
Y. Huang
Apolipoprotein E and Alzheimer disease
Neurology, January 24, 2006; 66(1_suppl_1): S79 - S85.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Peters-Libeu, Y. Newhouse, D. M. Hatters, and K. H. Weisgraber
Model of Biologically Active Apolipoprotein E Bound to Dipalmitoylphosphatidylcholine
J. Biol. Chem., January 13, 2006; 281(2): 1073 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Ramaswamy, Q. Xu, Y. Huang, and K. H. Weisgraber
Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain
J. Neurosci., November 16, 2005; 25(46): 10658 - 10663.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Hatters, M. S. Budamagunta, J. C. Voss, and K. H. Weisgraber
Modulation of Apolipoprotein E Structure by Domain Interaction: DIFFERENCES IN LIPID-BOUND AND LIPID-FREE FORMS
J. Biol. Chem., October 7, 2005; 280(40): 34288 - 34295.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. M. Hatters, C. A. Peters-Libeu, and K. H. Weisgraber
Engineering Conformational Destabilization into Mouse Apolipoprotein E: A MODEL FOR A UNIQUE PROPERTY OF HUMAN APOLIPOPROTEIN E4
J. Biol. Chem., July 15, 2005; 280(28): 26477 - 26482.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Zhang, M. H. Picard, E. Vasile, Y. Zhu, R. L. Raffai, K. H. Weisgraber, and M. Krieger
Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice
Circulation, June 28, 2005; 111(25): 3457 - 3464.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Futamura, P. Dhanasekaran, T. Handa, M. C. Phillips, S. Lund-Katz, and H. Saito
Two-step Mechanism of Binding of Apolipoprotein E to Heparin: IMPLICATIONS FOR THE KINETICS OF APOLIPOPROTEIN E-HEPARAN SULFATE PROTEOGLYCAN COMPLEX FORMATION ON CELL SURFACES
J. Biol. Chem., February 18, 2005; 280(7): 5414 - 5422.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Xu, W. J. Brecht, K. H. Weisgraber, R. W. Mahley, and Y. Huang
Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer
J. Biol. Chem., June 11, 2004; 279(24): 25511 - 25516.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr.
Molecular interactions between apoE and ABCA1: impact on apoE lipidation
J. Lipid Res., May 1, 2004; 45(5): 839 - 848.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
N. B. Chauhan
Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease
J. Lipid Res., November 1, 2003; 44(11): 2019 - 2029.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz
Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E
J. Biol. Chem., October 17, 2003; 278(42): 40723 - 40729.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. L. Raffai, R. McPherson, K. H. Weisgraber, T. L. Innerarity, E. Rassart, T. P. Bersot, and R. W. Milne
Antibody Phenotyping Test for the Human Apolipoprotein E2 Isoform
Clin. Chem., September 1, 2003; 49(9): 1524 - 1526.
[Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. L. Raffai and K. H. Weisgraber
Cholesterol: from heart attacks to Alzheimer's disease
J. Lipid Res., August 1, 2003; 44(8): 1423 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Saito, P. Dhanasekaran, D. Nguyen, F. Baldwin, K. H. Weisgraber, S. Wehrli, M. C. Phillips, and S. Lund-Katz
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
J. Biol. Chem., April 18, 2003; 278(17): 14782 - 14787.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Morrow, D. M. Hatters, B. Lu, P. Hochtl, K. A. Oberg, B. Rupp, and K. H. Weisgraber
Apolipoprotein E4 Forms a Molten Globule. A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE
J. Biol. Chem., December 20, 2002; 277(52): 50380 - 50385.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. L. Segall, P. Dhanasekaran, F. Baldwin, G. M. Anantharamaiah, K. H. Weisgraber, M. C. Phillips, and S. Lund-Katz
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization
J. Lipid Res., October 1, 2002; 43(10): 1688 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
K.R. Bales, J.C. Dodart, R.B. DeMattos, D.M. Holtzman, and S.M. Paul
Apolipoprotein E, Amyloid, and Alzheimer Disease
Mol. Interv., October 1, 2002; 2(6): 363 - 375.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Raussens, C. M. Slupsky, R. O. Ryan, and B. D. Sykes
NMR Structure and Dynamics of a Receptor-active Apolipoprotein E Peptide
J. Biol. Chem., August 2, 2002; 277(32): 29172 - 29180.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Raffai and K. H. Weisgraber
Hypomorphic Apolipoprotein E Mice. A NEW MODEL OF CONDITIONAL GENE REPAIR TO EXAMINE APOLIPOPROTEIN E-MEDIATED METABOLISM
J. Biol. Chem., March 22, 2002; 277(13): 11064 - 11068.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole
The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse
J. Neurosci., November 1, 2001; 21(21): 8370 - 8377.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Simons, P. Keller, J. Dichgans, and J. B. Schulz
Cholesterol and Alzheimer's disease: Is there a link?
Neurology, September 25, 2001; 57(6): 1089 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber
Introduction of human apolipoprotein E4 ""domain interaction"" into mouse apolipoprotein E
PNAS, September 5, 2001; (2001) 201279298.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. V. Chochina, N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood
Amyloid {beta}-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region
J. Lipid Res., August 1, 2001; 42(8): 1292 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS, July 5, 2001; (2001) 151254698.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. M. Ong, N. C. Zorapapel, K. A. Rich, R. E. Wagstaff, R. W. Lambert, S. E. Rosenberg, F. Moghaddas, A. Pirouzmanesh, A. M. Aoki, and M. C. Kenney
Effects of Cholesterol and Apolipoprotein E on Retinal Abnormalities in ApoE-Deficient Mice
Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1891 - 1900.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Lund-Katz, S. Wehrli, M. Zaiou, Y. Newhouse, K. H. Weisgraber, and M. C. Phillips
Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE
J. Lipid Res., June 1, 2001; 42(6): 894 - 901.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Kojro, G. Gimpl, S. Lammich, W. März, and F. Fahrenholz
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10
PNAS, April 12, 2001; (2001) 81612998.
[Abstract] [Full Text]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. B. Frisoni, J. Louhija, C. Geroldi, and M. Trabucchi
Longevity and the {{varepsilon}}2 Allele of Apolipoprotein E: The Finnish Centenarians Study
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 75M - 78.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
M. Morishima-Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshimura, S. Sugihara, and Y. Ihara
Effect of Apolipoprotein E Allele {{epsilon}}4 on the Initial Phase of Amyloid {beta}-Protein Accumulation in the Human Brain
Am. J. Pathol., December 1, 2000; 157(6): 2093 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Kumar-Singh, C. De Jonghe, M. Cruts, R. Kleinert, R. Wang, M. Mercken, B. De Strooper, H. Vanderstichele, A. Lofgren, I. Vanderhoeven, et al.
Nonfibrillar diffuse amyloid deposition due to a {gamma}42-secretase site mutation points to an essential role for N-truncated A{beta}42 in Alzheimer's disease
Hum. Mol. Genet., November 1, 2000; 9(18): 2589 - 2598.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. Dong, M. E. Balestra, Y. M. Newhouse, and K. H. Weisgraber
Human apolipoprotein E7: lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins
J. Lipid Res., November 1, 2000; 41(11): 1783 - 1789.
[Abstract] [Full Text]

Home page
 J. Med. Genet.Home page
K. M Mattila, J. O Rinne, M. Röyttä, P. Laippala, T. Pietilä, H. Kalimo, T. Koivula, H. Frey, and T. Lehtimäki
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon 4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology
J. Med. Genet., October 1, 2000; 37(10): 766 - 770.
[Abstract] [Full Text]

Home page
 Ann. N. Y. Acad. Sci.Home page
P. AMOUYEL, F. RICHARD, C. BERR, I. DAVID-FROMENTIN, and N. HELBECQUE
The Renin Angiotensin System and Alzheimer's Disease
Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 437 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Raber, S. F. Akana, S. Bhatnagar, M. F. Dallman, D. Wong, and L. Mucke
Hypothalamic-Pituitary-Adrenal Dysfunction in Apoe-/- Mice: Possible Role in Behavioral and Metabolic Alterations
J. Neurosci., March 1, 2000; 20(5): 2064 - 2071.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C Geroldi, M P Laakso, C DeCarli, A Beltramello, A Bianchetti, H Soininen, M Trabucchi, and G B Frisoni
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study
J. Neurol. Neurosurg. Psychiatry, January 1, 2000; 68(1): 93 - 96.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Bales, T. Verina, D. J. Cummins, Y. Du, R. C. Dodel, J. Saura, C. E. Fishman, C. A. DeLong, P. Piccardo, V. Petegnief, et al.
Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease
PNAS, December 21, 1999; 96(26): 15233 - 15238.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. W. Mahley, Y. Huang, and S. C. Rall , Jr.
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes
J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
M. Buttini, M. Orth, S. Bellosta, H. Akeefe, R. E. Pitas, T. Wyss-Coray, L. Mucke, and R. W. Mahley
Expression of Human Apolipoprotein E3 or E4 in the Brains of Apoe-/- Mice: Isoform-Specific Effects on Neurodegeneration
J. Neurosci., June 15, 1999; 19(12): 4867 - 4880.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. W. Mahley and Z.-S. Ji
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
J. Lipid Res., January 1, 1999; 40(1): 1 - 16.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
C. A. Fisher and R. O. Ryan
Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E
J. Lipid Res., January 1, 1999; 40(1): 93 - 99.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Russo, G. Angelini, D. Dapino, A. Piccini, G. Piombo, G. Schettini, S. Chen, J. K. Teller, D. Zaccheo, P. Gambetti, et al.
Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease
PNAS, December 22, 1998; 95(26): 15598 - 15602.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Raussens, C. A. Fisher, E. Goormaghtigh, R. O. Ryan, and J.-M. Ruysschaert
The Low Density Lipoprotein Receptor Active Conformation of Apolipoprotein E. HELIX ORGANIZATION IN N-TERMINAL DOMAIN-PHOSPHOLIPID DISC PARTICLES
J. Biol. Chem., October 2, 1998; 273(40): 25825 - 25830.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Raber, D. Wong, M. Buttini, M. Orth, S. Bellosta, R. E. Pitas, R. W. Mahley, and L. Mucke
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females
PNAS, September 1, 1998; 95(18): 10914 - 10919.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
D. Galasko, L. Chang, R. Motter, C. M. Clark, J. Kaye, D. Knopman, R. Thomas, D. Kholodenko, D. Schenk, I. Lieberburg, et al.
High Cerebrospinal Fluid Tau and Low Amyloid {beta}42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype
Arch Neurol, July 1, 1998; 55(7): 937 - 945.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. S. Howland, S. P. Trusko, M. J. Savage, A. G. Reaume, D. M. Lang, J. D. Hirsch, N. Maeda, R. Siman, B. D. Greenberg, R. W. Scott, et al.
Modulation of Secreted beta -Amyloid Precursor Protein and Amyloid beta -Peptide in Brain by Cholesterol
J. Biol. Chem., June 26, 1998; 273(26): 16576 - 16582.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-S. Ji, R. E. Pitas, and R. W. Mahley
Differential Cellular Accumulation/Retention of Apolipoprotein E Mediated by Cell Surface Heparan Sulfate Proteoglycans. APOLIPOPROTEINS E3 AND E2 GREATER THAN E4
J. Biol. Chem., May 29, 1998; 273(22): 13452 - 13460.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
Y. Sun, S. Wu, G. Bu, M. K. Onifade, S. N. Patel, M. J. LaDu, A. M. Fagan, and D. M. Holtzman
Glial Fibrillary Acidic Protein-Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins
J. Neurosci., May 1, 1998; 18(9): 3261 - 3272.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. K. Avramoglu, J. Nimpf, R. S. McLeod, K. W. S. Ko, Y. Wang, D. FitzGerald, and Z. Yao
Functional Expression of the Chicken Low Density Lipoprotein Receptor-related Protein in a Mutant Chinese Hamster Ovary Cell Line Restores Toxicity of Pseudomonas Exotoxin A and Degradation of alpha 2-Macroglobulin
J. Biol. Chem., March 13, 1998; 273(11): 6057 - 6065.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. M. Allan, S. Taylor, and J. M. Taylor
Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster
J. Biol. Chem., November 14, 1997; 272(46): 29113 - 29119.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. J. Babin, C. Thisse, M. Durliat, M. Andre, M.-A. Akimenko, and B. Thisse
Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development
PNAS, August 5, 1997; 94(16): 8622 - 8627.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. I. Brazil, H. Chung, and F. R. Maxfield
Effects of Incorporation of Immunoglobulin G and Complement Component C1q on Uptake and Degradation of Alzheimer's Disease Amyloid Fibrils by Microglia
J. Biol. Chem., May 26, 2000; 275(22): 16941 - 16947.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Lu, J. A. Morrow, and K. H. Weisgraber
Conformational Reorganization of the Four-helix Bundle of Human Apolipoprotein E in Binding to Phospholipid
J. Biol. Chem., June 30, 2000; 275(27): 20775 - 20781.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Saito, P. Dhanasekaran, F. Baldwin, K. H. Weisgraber, S. Lund-Katz, and M. C. Phillips
Lipid Binding-induced Conformational Change in Human Apolipoprotein E. EVIDENCE FOR TWO LIPID-BOUND STATES ON SPHERICAL PARTICLES
J. Biol. Chem., October 26, 2001; 276(44): 40949 - 40954.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Kojro, G. Gimpl, S. Lammich, W. Marz, and F. Fahrenholz
From the Cover: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10
PNAS, May 8, 2001; 98(10): 5815 - 5820.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Huang, X. Q. Liu, T. Wyss-Coray, W. J. Brecht, D. A. Sanan, and R. W. Mahley
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
PNAS, July 17, 2001; 98(15): 8838 - 8843.
[Abstract] [Full Text] [PDF]